Skip to main content

Voices from the Doximity Network

Browse Contribute

Toggle Menu

All Articles Trending Lessons Learned Challenges in Medicine Expert Insights

Jonathan Rosenberg, MD

Oncology

•

FDA Grants Enfortumab Vedotin Breakthrough Designation for Urothelial Carcinoma

Op-Med provides clinician authors like you a place to share thoughts, opinions, and knowledge with the largest medical community in the United States.

Get the Doximity App